The Genetics of Bronchopulmonary Dysplasia

Seminars in Perinatology

Volumn 30, Issue 4, 2006, Pages 185-191

  Bhandari, Vineet ^a   Gruen, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cytokine; lung; preterm newborn; single nucleotide polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UROKINASE;

ANEUPLOIDY; ARTIFICIAL VENTILATION; BAROTRAUMA; CHROMOSOME ABERRATION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; FETUS CIRCULATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HERITABILITY; HUMAN; HYPERCAPNIA; HYPEROXIA; INBORN ERROR OF METABOLISM; INFLAMMATION; LUNG DEVELOPMENT; LUNG DYSPLASIA; MORBIDITY; MORTALITY; MULTIPLE PREGNANCY; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE;

BRONCHOPULMONARY DYSPLASIA; ENZYMES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MULTIPLE BIRTH OFFSPRING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 33745964204     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2006.05.005     Document Type: Review

References (53)

1. Fanaroff A.A., Hack M., and Walsh M.C. The NICHD neonatal research network. changes in practice and outcomes during the first 15 years. Semin Perinatol 27 (2003) 281-287
2. Bhandari A., and Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 8 (2003) e370-e380
3. Lyon A. Chronic lung disease of prematurity. The role of intra-uterine infection. Eur J Pediatr 159 (2000) 798-802
4. Ambalavanan N., and Carlo W.A. Bronchopulmonary dysplasia. new insights. Clin Perinatol 31 (2004) 613-628
5. Stocker J.T. Pathologic features of long-standing "healed" bronchopulmonary dysplasia. a study of 28 3- to 40-month-old infants. Hum Pathol 17 (1986) 943-961
6. Bhatt A.J., Pryhuber G.S., Huyck H., et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164 (2001) 1971-1980
7. Coalson J.J., Winter V.T., Siler-Khodr T., et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160 (1999) 1333-1346
8. Husain A.N., Siddiqui N.H., and Stocker J.T. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29 (1998) 710-717
9. Zdravkovic S., Wienke A., Pedersen N.L., et al. Heritability of death from coronary heart disease. a 36-year follow-up of 20 966 Swedish twins. J Intern Med 252 (2002) 247-254
10. Agarwal A., Williams G.H., and Fisher N.D. Genetics of human hypertension. Trends Endocrinol Metab 16 (2005) 127-133
11. Pharoah P.D., Dunning A.M., Ponder B.A., et al. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4 (2004) 850-860
12. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer. analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343 (2000) 78-85
13. Kendler K.S., Prescott C.A., Jacobson K., et al. The joint analysis of personal interview and family history diagnoses. evidence for validity of diagnosis and increased heritability estimates. Psychol Med 32 (2002) 829-842
14. Tandon K., and McGuffin P. The genetic basis for psychiatric illness in man. Eur J Neurosci 16 (2002) 403-407
15. Childs B. Medicine in a genetic context. In: Rimoin D., Connor J., Pyeritz R., and Korf B. (Eds). Emery and Rimoin's Principles and Practice of Medical Genetics (2002), Livingstone, New York, NY 37-55
16. Chen S.J., Vohr B.R., and Oh W. Effects of birth order, gender, and intrauterine growth retardation on the outcome of very low birth weight in twins. J Pediatr 123 (1993) 132-136
17. Nielsen H.C., Harvey-Wilkes K., MacKinnon B., and Hung S. Neonatal outcome of very premature infants from multiple and singleton gestations. Am J Obstet Gynecol 177 (1997) 653-659
18. Shinwell E.S., Blickstein I., Lusky A., and Reichman B. Effect of birth order on neonatal morbidity and mortality among very low birthweight twins. a population based study. Arch Dis Child Fetal Neonatal Ed 89 (2004) F145-F148
19. Parker R.A., Lindstrom D.P., and Cotton R.B. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 20 (1996) 206-209
20. Bhandari V., Bizzarro M.J., Shetty A.H., et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117 (2006) 1901-1906
21. Candido R., Burrell L.M., Jandeleit-Dahm K.A., and Cooper M.E. Vasoactive peptides and the kidney. In: Brenner B.M., and Rector F.C. (Eds). The Kidney. (ed 7) (2004), Elsevier, Philadelphia, PA 668-670
22. Yanamandra K., Loggins J., and Baier R.J. The Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. BMC Pediatr 4 (2004) 26
23. Kazzi S.N., and Quasney M.W. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J Pediatr 147 6 (2005) 818-822
24. Hayes J.D., and Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
25. Spiteri M.A., Bianco A., Strange R.C., and Fryer A.A. Polymorphisms at the glutathione S-transferase, GSTP1 locus. a novel mechanism for susceptibility and development of atopic airway inflammation. Allergy 55 suppl 61 (2000) 15-20
26. Manar M.H., Brown M.R., Gauthier T.W., and Brown L.A. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 24 (2004) 30-35
27. Hellstrom A., Engstrom E., Hard A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112 (2003) 1016-1020
28. Chetty A., Andersson S., Lassus P., and Nielsen H.C. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol 37 (2004) 128-136
29. Balogh A., Treszl A., Vannay A., and Vasarhelyi B. A prevalent functional polymorphism of insulin-like growth factor system is not associated with perinatal complications in preterm infants. Pediatrics 117 (2006) 591-592
30. Bonafe M., Barbieri M., Marchegiani F., et al. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity. cues for an evolutionarily conserved mechanism of life span control. J Clin Endocrinol Metab 88 (2003) 3299-3304
31. Lin H.C., Su B.H., Chang J.S., et al. Nonassociation of interleukin 4 intron 3 and 590 promoter polymorphisms with bronchopulmonary dysplasia for ventilated preterm infants. Biol Neonate 87 (2005) 181-186
32. Kilpatrick L., and Harris M.C. Cytokines and inflammatory response in the fetus and newborn. In: Polin R.A., Fox W.W., and Abman S.H. (Eds). Fetal and Neonatal Physiology. (ed 3) (2004), WB Saunders, Philadelphia, PA 1560-1561
33. Turner D.M., Williams D.M., Sankaran D., et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
34. Yanamandra K., Boggs P., Loggins J., and Baier R.J. Interleukin-10-1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol 39 (2005) 426-432
35. Baier R.J., Majid A., Parupia H., et al. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 37 (2004) 137-148
36. Adcock K., Hedberg C., Loggins J., et al. The TNF-alpha -308, MCP-1-2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 4 (2003) 420-426
37. Yurdakok M. Inherited disorders of neonatal lung diseases. Turk J Pediatr 46 (2004) 105-114
38. Marttila R., Haataja R., Guttentag S., and Hallman M. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med 168 (2003) 1216-1222
39. Van Golde L.M., Batenburg J.J., and Robertson B. The pulmonary surfactant system. biochemical aspects and functional significance. Physiol Rev 68 (1988) 374-455
40. Srisuparp P., Marks J.D., Khoshnood B., and Schreiber M.D. Predictive power of initial severity of pulmonary disease for subsequent development of bronchopulmonary dysplasia. Biol Neonate 84 (2003) 31-36
41. Weber B., Borkhardt A., Stoll-Becker S., et al. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Turk J Pediatr 42 (2000) 181-185
42. Whitsett J.A., Nogee L.M., Weaver T.E., and Horowitz A.D. Human surfactant protein B. structure, function, regulation, and genetic disease. Physiol Rev 75 (1995) 749-757
43. Dunbar III A.E., Wert S.E., Ikegami M., et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 48 (2000) 275-282
44. Clark J.C., Weaver T.E., Iwamoto H.S., et al. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol 16 (1997) 46-52
45. Makri V., Hospes B., Stoll-Becker S., et al. Polymorphisms of surfactant protein B encoding gene. modifiers of the course of neonatal respiratory distress syndrome?. Eur J Pediatr 161 (2002) 604-608
46. Rova M., Haataja R., Marttila R., et al. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 13 (2004) 1095-1104
47. Shull M.M., Ormsby I., Kier A.B., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
48. Vicencio A.G., Lee C.G., Cho S.J., et al. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung. a new model for bronchopulmonary dysplasia?. Am J Respir Cell Mol Biol 31 (2004) 650-656
49. Jonsson B., Tullus K., Brauner A., et al. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 77 (1997) F198-F201
50. Tullus K., Noack G.W., Burman L.G., et al. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 155 (1996) 112-116
51. Kazzi S.N., Kim U.O., Quasney M.W., and Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 114 (2004) e243-e248
52. Wu H.C., Chang C.H., Chen W.C., et al. Urokinase gene 3′-UTR T/C polymorphism is not associated with bladder cancer. Genet Mol Biol 27 (2004) 15-16
53. Lin H.C., Su B.H., Lin T.W., et al. No association of urokinase gene 3′-UTR polymorphism with bronchopulmonary dysplasia for ventilated preterm infants. Acta Paediatr Taiwan 45 (2004) 315-319